R T Tsuyuki

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. ncbi request reprint Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus)
    Carol Yamada
    Pharmacy Department, Grey Nuns Community Health Centre, Edmonton, Alberta, Canada
    Pharmacotherapy 25:110-5. 2005
  2. pmc Effect of fish oil on arrhythmias and mortality: systematic review
    Hernando Leon
    Epidemiology Coordinating and Research EPICORE Centre, Edmonton, AB, Canada
    BMJ 337:a2931. 2008
  3. pmc Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality
    Dean T Eurich
    School of Public Health, University of Alberta, Edmonton, Alberta, T6G 2G3, Canada
    Trials 10:12. 2009
  4. pmc The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788]
    Finlay A McAlister
    Division of General Internal Medicine, University of Alberta Hospital, 8440 112 Street, Edmonton, Canada
    Implement Sci 5:27. 2010
  5. pmc A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]
    Sumit R Majumdar
    Department of Medicine, University of Alberta, Edmonton AB and the Institute of Health Economics, Edmonton AB, Canada
    BMC Cardiovasc Disord 5:17. 2005
  6. ncbi request reprint Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus)
    Ross T Tsuyuki
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Med 116:130-3. 2004
  7. pmc Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods
    Theresa L Charrois
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Implement Sci 6:94. 2011
  8. doi request reprint Prevalence and treatment patterns of lower extremity peripheral arterial disease among patients at risk in ambulatory health settings
    Mark Makowsky
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Can J Cardiol 27:389.e11-8. 2011
  9. ncbi request reprint Contemporary burden of illness of congestive heart failure in Canada
    Ross T Tsuyuki
    Epidemiology Coordinating and Research, Division of Cardiology, University of Alberta, Edmonton, Canada
    Can J Cardiol 19:436-8. 2003
  10. ncbi request reprint Angiotensin receptor blockers do not increase risk of myocardial infarction
    Ross T Tsuyuki
    EPICORE Centre, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, 220 College Plaza, University of Alberta Campus, Edmonton, Alberta, Canada T6G 2C8
    Circulation 114:855-60. 2006

Detail Information

Publications82

  1. ncbi request reprint Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus)
    Carol Yamada
    Pharmacy Department, Grey Nuns Community Health Centre, Edmonton, Alberta, Canada
    Pharmacotherapy 25:110-5. 2005
    ....
  2. pmc Effect of fish oil on arrhythmias and mortality: systematic review
    Hernando Leon
    Epidemiology Coordinating and Research EPICORE Centre, Edmonton, AB, Canada
    BMJ 337:a2931. 2008
    ..To synthesise the literature on the effects of fish oil-docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)-on mortality and arrhythmias and to explore dose response and formulation effects...
  3. pmc Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality
    Dean T Eurich
    School of Public Health, University of Alberta, Edmonton, Alberta, T6G 2G3, Canada
    Trials 10:12. 2009
    ..Therefore, we attempted to conduct a pilot study to evaluate the feasibility of undertaking a large randomized controlled trial with clinical endpoints...
  4. pmc The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788]
    Finlay A McAlister
    Division of General Internal Medicine, University of Alberta Hospital, 8440 112 Street, Edmonton, Canada
    Implement Sci 5:27. 2010
    ..If our intervention improves the provision of secondary prevention therapies in these patients, the clinical (and financial) implications will be enormous...
  5. pmc A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]
    Sumit R Majumdar
    Department of Medicine, University of Alberta, Edmonton AB and the Institute of Health Economics, Edmonton AB, Canada
    BMC Cardiovasc Disord 5:17. 2005
    ....
  6. ncbi request reprint Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus)
    Ross T Tsuyuki
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Med 116:130-3. 2004
  7. pmc Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods
    Theresa L Charrois
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Implement Sci 6:94. 2011
    ..With Alberta being the first province in Canada to have independent prescribing by pharmacists, it offers a unique opportunity to evaluate outcomes in patients who are prescribed antihypertensive therapy by pharmacists...
  8. doi request reprint Prevalence and treatment patterns of lower extremity peripheral arterial disease among patients at risk in ambulatory health settings
    Mark Makowsky
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Can J Cardiol 27:389.e11-8. 2011
    ..Lower extremity peripheral arterial disease (PAD) is underdiagnosed and undertreated in Canada, although data are limited. We sought to measure PAD prevalence and treatment patterns in ambulatory settings...
  9. ncbi request reprint Contemporary burden of illness of congestive heart failure in Canada
    Ross T Tsuyuki
    Epidemiology Coordinating and Research, Division of Cardiology, University of Alberta, Edmonton, Canada
    Can J Cardiol 19:436-8. 2003
    ..Congestive heart failure (CHF) is associated with high morbidity and mortality; however, there is little contemporary Canadian data to quantify the burden of this illness...
  10. ncbi request reprint Angiotensin receptor blockers do not increase risk of myocardial infarction
    Ross T Tsuyuki
    EPICORE Centre, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, 220 College Plaza, University of Alberta Campus, Edmonton, Alberta, Canada T6G 2C8
    Circulation 114:855-60. 2006
  11. ncbi request reprint A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
    Ross T Tsuyuki
    Epidemiology Coordinating and Research EPICORE Centre, Division of Cardiology, University of Alberta, 213 Heritage Medical Research Centre, Edmonton, Alberta, Canada T6G 2S2
    Arch Intern Med 162:1149-55. 2002
    ..This study aimed to determine the effect of a program of community pharmacist intervention on the process of cholesterol risk management in patients at high risk for cardiovascular events...
  12. ncbi request reprint Acute precipitants of congestive heart failure exacerbations
    R T Tsuyuki
    Epidemiology Coordinating and Research EPICORE Centre, Division of Cardiology, University of Alberta, 213 Heritage Medical Research Centre, Edmonton, Alberta, Canada T6G 2S2
    Arch Intern Med 161:2337-42. 2001
    ..The objective of this study was to prospectively describe the precipitants associated with exacerbation of CHF status in patients enrolled in the Randomized Evaluation of Strategies for Left Ventricular Dysfunction Pilot Study...
  13. ncbi request reprint Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists
    S H Simpson
    Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 21:627-35. 2001
    ..The incremental cost to provide the program appeared minimal from both government and pharmacy manager perspectives. It is hoped that these results could support negotiations for reimbursement of clinical pharmacy services with payors...
  14. ncbi request reprint Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk
    R T Tsuyuki
    Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Ann Pharmacother 33:910-9. 1999
    ..To determine the efficacy of a program of intervention by pharmacists on lipid risk management in patients at high risk for cardiovascular events...
  15. ncbi request reprint Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
    Scot H Simpson
    Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 24:389-94. 2004
    ..To determine the effect of enhanced pharmacist care on cholesterol management in patients with and without diabetes mellitus...
  16. ncbi request reprint Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial
    Sumit R Majumdar
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am Heart J 153:22.e1-8. 2007
    ....
  17. doi request reprint Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial
    N N Ladhani
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
    Diabet Med 29:1433-9. 2012
    ..To determine the impact of adding pharmacists to primary care teams on predicted 10-year risk of cardiovascular events in patients with Type 2 diabetes without established cardiovascular disease...
  18. ncbi request reprint Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
    Dean T Eurich
    Institute of Health Economics, Edmonton, Alberta, Canada
    Diabetes Care 28:2345-51. 2005
    ..The aim of this study was to evaluate the association between metformin and clinical outcomes in patients with heart failure and type 2 diabetes...
  19. ncbi request reprint Development and validation of a survey to assess barriers to drug use in patients with chronic heart failure
    Scot H Simpson
    Institute of Health Economics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 22:1163-72. 2002
    ..Conclusion. The BMU survey demonstrated reasonable reliability and validity characteristics in this first clinical experience. Despite high adherence, patients still reported barriers that may hinder optimal drug use...
  20. ncbi request reprint A multicenter disease management program for hospitalized patients with heart failure
    Ross T Tsuyuki
    Division of Cardiology and Department of Public Health Sciences, Faculty of Medicine and Dentistry, University of Alberta, 220 College Plaza, Edmonton, Canada T6G 2C8
    J Card Fail 10:473-80. 2004
    ..In this 2-stage, multicenter trial, we evaluated the effect of a disease management program on clinical and economic outcomes in patients with HF...
  21. pmc Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis
    Lauren C Brown
    Department of Public Health Sciences, University of Alberta, and the Institute of Health Economics, Edmonton
    CMAJ 171:1189-92. 2004
    ..e., coronary artery disease [CAD], cerebrovascular disease [CBVD] or peripheral arterial disease [PAD])...
  22. doi request reprint Evaluation of attitudes and perceptions of key clinical stakeholders regarding out-of-hospital diagnosis and treatment of ST elevation myocardial infarction patients using a region-wide survey
    N A Rajabali
    Epidemiology Coordinating and Research EPICORE Centre, University of Alberta, Edmonton, Alberta, Canada
    Emerg Med J 26:371-6. 2009
    ..The purpose of this study was to evaluate perceptions among healthcare stakeholder groups relating to the barriers and facilitators of implementing a PHM programme...
  23. ncbi request reprint Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials
    P Tandon
    Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
    Aliment Pharmacol Ther 25:1017-28. 2007
    ..Although reversal of pretransplant renal dysfunction in hepatorenal syndrome reduces post-transplant complications, the overall impact on morbidity and mortality requires clarification...
  24. pmc Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience
    Glen J Pearson
    Department of Medicine, Divisions of Cardiology, Cardiovascular Risk Reduction Clinic, University of Alberta Hospital, Edmonton, Alberta, Canada
    Vasc Health Risk Manag 4:1127-35. 2008
    ..We evaluated the impact of a CRRC on lipid levels and assessed the long-term effect of a CRRC in maintaining improved lipid levels following discharge...
  25. pmc The Enhancing Secondary Prevention in Coronary Artery Disease trial
    Finlay A McAlister
    Department of Medicine, University of Alberta, the Royal Alexandra Hospital, Edmonton, Alberta
    CMAJ 181:897-904. 2009
    ..We evaluated whether evidence summaries, which were either unsigned or signed by local opinion leaders, improved the quality of secondary prevention care delivered by primary care physicians of patients with coronary artery disease...
  26. ncbi request reprint Validity and reliability of the Edmonton Frail Scale
    Darryl B Rolfson
    Division of Geriatric Medicine, University of Alberta, B139C Clin Sci Building, 8440 112 Street, Edmonton, Alberta, Canada, T6G 2B7
    Age Ageing 35:526-9. 2006
  27. pmc A meta-analysis of the association between adherence to drug therapy and mortality
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2N8
    BMJ 333:15. 2006
    ..To evaluate the relation between adherence to drug therapy, including placebo, and mortality...
  28. doi request reprint Patient and informal caregivers' knowledge of heart failure: necessary but insufficient for effective self-care
    Alexander M Clark
    Faculty of Nursing, Level 3 CSB, University of Alberta, Edmonton, AB, Canada T6R 2R6
    Eur J Heart Fail 11:617-21. 2009
    ..We aimed to examine the individual and contextual factors perceived by patients and their informal caregivers' to influence their willingness and capacity to undertake effective HF self-care...
  29. ncbi request reprint Exploring the treatment-risk paradox in coronary disease
    Finlay A McAlister
    University of Alberta, Edmonton, Alberta, Canada T6G 2R7
    Arch Intern Med 167:1019-25. 2007
    ..The cause of the "treatment-risk paradox" reported for patients with coronary disease is unknown; however, determining the factors that contribute to this paradox is essential to properly design quality improvement interventions...
  30. doi request reprint The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study
    Puneeta Tandon
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Liver Int 29:169-74. 2009
    ....
  31. pmc Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial
    Scot H Simpson
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Alberta, Canada
    Diabetes Care 34:20-6. 2011
    ..To evaluate the effect of adding pharmacists to primary care teams on the management of hypertension and other cardiovascular risk factors in patients with type 2 diabetes...
  32. ncbi request reprint Effects of the 1994 Canadian Cardiovascular Society clinical practice guidelines for congestive heart failure
    Ross T Tsuyuki
    University of Alberta, Edmonton, Canada
    Can J Cardiol 18:147-52. 2002
    ..In 1994, the Canadian Cardiovascular Society (CCS) issued practice guidelines for the management of congestive heart failure (CHF), which strongly recommended the use of angiotensin-converting enzyme (ACE) inhibitors...
  33. doi request reprint Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial
    N Yuksel
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 3126 Dentistry Pharmacy Centre, Edmonton, AB, T6G 2N8, Canada
    Osteoporos Int 21:391-8. 2010
    ..Twice as many patients who got the intervention received further testing or treatment for osteoporosis...
  34. ncbi request reprint Economic implications of treatment guidelines for congestive heart failure
    Marcelo C Shibata
    University of Alberta, Edmonton
    Can J Cardiol 21:1301-6. 2005
    ..3 million dollars, giving a net savings of 2.3 million dollars in the first year. The implementation of evidence-based therapy for CHF treatment is not only clinically efficacious, but also economically attractive...
  35. pmc Management of hypertension in elderly long-term care residents
    Ross T Tsuyuki
    Department of Medicine, University of Alberta, Alberta, Canada
    Can J Cardiol 24:912-4. 2008
    ..To determine the adequacy of hypertension management in institutionalized elderly patients...
  36. doi request reprint "If he gives in, he will be gone...": the influence of work and place on experiences, reactions and self-care of heart failure in rural Canada
    Nicole Freydberg
    Faculty of Nursing, University of Alberta, Clinical Sciences Building, Edmonton, Alberta, Canada
    Soc Sci Med 70:1077-83. 2010
    ..Accounts of HF and its self-care were grounded in work and place-related dimensions of the rural setting. Approaches and interventions related to chronic disease must engage with place and work-related dimensions of context...
  37. ncbi request reprint Levels of evidence in cardiovascular clinical practice guidelines
    M L Ackman
    University of Alberta Hospital, Edmonton, Canada
    Can J Cardiol 16:1249-54. 2000
    ....
  38. ncbi request reprint Practice-based research: lessons from community pharmacist participants
    S H Simpson
    EPICORE Center, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Pharmacotherapy 21:731-9. 2001
    ..Second, it provides needed data to demonstrate the value of enhanced pharmacy practice. Thorough understanding of pharmacists' opinions is necessary to optimize the design of future studies...
  39. doi request reprint The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic review
    M C Shibata
    EPICORE Centre, Division of Cardiology, University of Alberta, AB, Canada
    Int J Clin Pract 62:1397-402. 2008
    ..Trials evaluating angiotensin-receptor blockers in heart failure (HF) have shown inconsistent results...
  40. ncbi request reprint Lipid-lowering therapy and outcomes in heart failure
    Joel G Ray
    Department of Medicine, Divisions of General Internal Medicine and Endocrinology and Metabolism, St Michael s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, Canada
    J Cardiovasc Pharmacol Ther 12:27-35. 2007
    ..More data are needed before statins can be recommended in those with isolated heart failure...
  41. ncbi request reprint Patients' achievement of cholesterol targets: a cross-sectional evaluation
    Kari L Olson
    Epidemiology Coordinating and Research Centre, Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2C8
    Am J Prev Med 25:339-42. 2003
    ..This study was conducted to determine the proportion of patients achieving recommended target lipid levels in a relatively unselected group of community-dwelling patients who were prescribed HMG-CoA reductase inhibitors (statins)...
  42. ncbi request reprint Reducing costs and improving hypertension management
    Vida Stankus
    EPICORE Centre, Department of Medicine, University of Alberta, Canada
    Can J Clin Pharmacol 16:e151-5. 2009
    ..To quantify the cost-savings that could be realized by switching patients from two separate agents, ACE inhibitor/ARB and thiazide diuretic, to a fixed dose combination product...
  43. ncbi request reprint Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes
    Dean T Eurich
    Institute of Health Economics 1200, 10405 Jasper Ave, Edmonton, Alberta, Canada T5J 3N4
    Diabetes Care 27:1330-4. 2004
    ..Subjects were prospectively followed until death or the end of 1999. Multivariate Cox proportional hazards models were used to assess differences in all-cause and cardiovascular-related mortality between cohort groups...
  44. pmc Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
    Dean T Eurich
    Institute of Health Economics, Edmonton, AB, Canada, T5J 3N4
    BMJ 335:497. 2007
    ..To review the literature on the association between antidiabetic agents and morbidity and mortality in people with heart failure and diabetes...
  45. pmc Angiotensin receptor blockers and risk of myocardial infarction: systematic review
    Michael A McDonald
    Division of Cardiology, University of Alberta, 2C2 WMC, University of Alberta Hospital, 8440 112 Street, Edmonton, AB, Canada T6G 2B7
    BMJ 331:873. 2005
    ..To evaluate the effect of angiotensin receptor blockers on the risk of myocardial infarction in patients at risk for cardiovascular events...
  46. ncbi request reprint Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization
    Kannayiram Alagiakrishnan
    Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada
    Am J Cardiol 96:639-42. 2005
    ..928). An abnormal T axis was a significant predictor of overall mortality (p = 0.035) for death at any time in our unadjusted survival analysis, and a trend toward poorer survival persisted after adjustment for clinical covariates...
  47. ncbi request reprint Relationship between number, timing, and type of pharmacist interventions and patient outcomes
    Theresa L Charrois
    Department of Medicine, University of Alberta, Edmonton, Canada
    Am J Health Syst Pharm 62:1798-801. 2005
  48. ncbi request reprint Utilization of evidence-based therapies for heart failure in the institutionalized elderly
    Marcelo C Shibata
    EPICORE Centre, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Canada
    Eur J Heart Fail 7:1122-5. 2005
    ..Little is known about their management. The aim of this study was to evaluate the use of evidence-based therapies in institutionalized elderly patients with HF...
  49. pmc Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study
    Scot H Simpson
    Institute of Health Economics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alta
    CMAJ 174:169-74. 2006
    ..The purpose of this study was to determine if the risk of death changes with level of exposure to sulfonylurea drugs...
  50. ncbi request reprint Stroke prophylaxis in nonvalvular atrial fibrillation
    T J Bungard
    EPICORE Centre, Division of Cardiology, Cardiology, University of Alberta, Edmonton, Alberta, Canada
    Curr Opin Neurol 14:59-65. 2001
    ..Narrowing this gap between research evidence and clinical practice may be accomplished by identifying those patients who are eligible for prophylaxis, and then maintaining them at an adequate level of anticoagulation...
  51. ncbi request reprint Poor adherence with hypolipidemic drugs: a lost opportunity
    R T Tsuyuki
    Division of Cardiology, University of Alberta, Edmonton, Canada
    Pharmacotherapy 21:576-82. 2001
    ..While the search for new, efficacious therapies must continue, efforts focused on improving adherence to proven therapy may have a greater overall impact on health than any single new agent...
  52. ncbi request reprint Primary health care teams: team members' perceptions of the collaborative process
    Sherry L Dieleman
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    J Interprof Care 18:75-8. 2004
  53. doi request reprint A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN)
    Donna L McLean
    EPICORE Centre COMPRIS, Division of Cardiology, University of Alberta, 220 College Plaza, Edmonton, AB T6G 2C8, Canada
    Arch Intern Med 168:2355-61. 2008
    ..This study aimed to determine the efficacy of a community-based multidisciplinary intervention on BP control in patients with diabetes mellitus...
  54. ncbi request reprint The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation
    Tammy J Bungard
    Division of Cardiology, University of Alberta, Edmonton
    Can J Cardiol 19:280-4. 2003
    ..The purpose of this study was to assess the relative importance of various barriers that may influence the prescription of warfarin in patients with nonvalvular atrial fibrillation...
  55. doi request reprint Pharmacist care of patients with heart failure: a systematic review of randomized trials
    Sheri L Koshman
    Division of Cardiology, Faculty of Medicine and Dentistry, EPICORE Centre COMPRIS, University of Alberta, 220 College Plaza, 8215 112 St NW, Edmonton, Alberta, AB T6G 2C8 Canada
    Arch Intern Med 168:687-94. 2008
    ..To clarify the role of pharmacists in the care of patients with HF, we performed a systematic review evaluating the effect of pharmacist care on patient outcomes in HF...
  56. pmc Evaluating the views of paramedics, cardiologists, emergency department physicians and nurses on advanced prehospital management of acute ST elevation myocardial infarction
    Naheed A Rajabali
    Walter C Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta T6G 2B7, Canada
    Can J Cardiol 25:e323-8. 2009
    ..Understanding perceived barriers to and facilitators of PHM implementation may support the expansion of programs, with associated patient benefit...
  57. doi request reprint Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]
    Mark J Makowsky
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Med Care 47:642-50. 2009
    ..We sought to determine whether collaborative care including a team-based clinical pharmacist improves the quality of prescribed drug therapy and reduces hospital readmission...
  58. ncbi request reprint Management of asthma among community-based primary care physicians
    Ross T Tsuyuki
    University of Alberta, Edmonton
    J Asthma 42:163-7. 2005
    ..Despite significant improvements in asthma treatment and the dissemination of national and international guidelines for asthma management, there are ongoing concerns that suboptimal care is being provided for patients with asthma...
  59. ncbi request reprint Development of educational materials for congestive-heart-failure patients
    Miriam Fradette
    Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
    Am J Health Syst Pharm 61:386-9. 2004
  60. ncbi request reprint The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes
    Puneeta Tandon
    Division of General Internal Medicine, University of Alberta, Edmonton, Canada
    Arch Intern Med 164:769-74. 2004
    ..Little is known about the dosing, tolerability, and impact of beta-blockers in nontrial participants. This study was conducted to evaluate the use and outcomes of beta-blockers in a tertiary care heart failure clinic...
  61. pmc Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure
    Crystal A Richter
    University of Alberta, Edmonton, Canada
    Can J Cardiol 25:e173-8. 2009
    ..Heart failure (HF) is a common emergency depart-ment (ED) presentation and a leading reason for hospitalization. Canadian practice patterns for the management of acute HF have not been well described...
  62. ncbi request reprint A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients
    David Feeny
    Institute of Health Economics, 1200, 10405 Jasper Avenue, Edmonton, Alberta, T5J 3N4, Canada
    J Clin Epidemiol 58:138-41. 2005
    ..The objective of this study was to examine the construct validity of the RAND-12 and HUI3 in the context of high-risk primary care patients...
  63. ncbi request reprint Underutilisation of ACE inhibitors in patients with congestive heart failure
    T J Bungard
    Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
    Drugs 61:2021-33. 2001
    ....
  64. doi request reprint Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting
    Mark J Makowsky
    Epidemiology Coordinating and Research EPICORE Centre, University of Alberta, Edmonton, Alberta, Canada
    J Interprof Care 23:169-84. 2009
    ..Focussed attention on how practice is structured, team process and ongoing support would enable successful implementation of team-based care in a larger context. (ClinicalTrials.gov number, NCT00351676)...
  65. ncbi request reprint Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation
    Elaine Lau
    Epidemiology Coordinating and Research Centre, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
    J Am Geriatr Soc 52:428-33. 2004
    ..To identify patterns and predictors of antithrombotic use and to evaluate the appropriateness of antithrombotic therapy for stroke prophylaxis in institutionalized elderly patients with atrial fibrillation...
  66. ncbi request reprint Completely autologous platelet gel in breast reduction surgery: a blinded, randomized, controlled trial
    Alexander Anzarut
    Division of Plastic and Reconstructive Surgery and the Department of Surgery, University of Alberta, Edmonton, Alberta, Canada
    Plast Reconstr Surg 119:1159-66. 2007
    ..However, there is a paucity of randomized, double-blind, controlled trials assessing the efficacy of these agents...
  67. doi request reprint Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results
    Theresa L Charrois
    EPICORE Centre, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    Ann Pharmacother 43:118-22. 2009
    ..Well-conducted systematic reviews of pharmacist interventions could go a long way toward changing pharmacy practice and healthcare policy to recognize the important impact that pharmacists could have in the healthcare system...
  68. pmc Revascularization in patients with heart failure
    Ross T Tsuyuki
    Division of Cardiology, University of Alberta, Edmonton, Alta
    CMAJ 175:361-5. 2006
    ..The objective of our study was to determine the association of coronary revascularization with survival in patients who have had heart failure...
  69. pmc Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers
    J Malcom O Arnold
    University of Western Ontario, London, Canada
    Can J Cardiol 23:21-45. 2007
    ....
  70. ncbi request reprint Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis
    Carlo A Marra
    Collaboration for Outcomes Research and Evaluation, University of British Columbia, Centre for Clinical Epidemiology and Evaluation, British Columbia, Canada
    Arthritis Rheum 57:1238-44. 2007
    ..Our objective was to determine if pharmacists, using a simple screening questionnaire, can identify individuals with previously undiagnosed knee OA...
  71. pmc Enhancing primary care for complex patients. Demonstration project using multidisciplinary teams
    Karen B Farris
    College of Pharmacy, University of Iowa, Iowa City 52240, USA
    Can Fam Physician 50:998-1003. 2004
    ..Communication between community-based providers is often sporadic and problem-focused...
  72. pmc Recruitment for a provincial asthma study. Participation of network and non-network primary care physicians
    Don D Sin
    Department of Medicine, University of British Columbia, Vancouver
    Can Fam Physician 50:1251-4. 2004
  73. pmc Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting
    Margaret L Ackman
    Regional Pharmacy Services, Capital Health
    Can J Cardiol 22:1205-8. 2006
    ..A prior authorization (PA) process for patients prescribed clopidogrel following stent insertion was changed to an authorized prescriber (AP) list process in March 2002...
  74. pmc Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management
    J Malcolm O Arnold
    University of Western Ontario, London, Canada
    Can J Cardiol 22:23-45. 2006
    ..The goal is to translate best evidence-based therapies into clinical practice with a measureable impact on the health of heart failure patients in Canada...
  75. ncbi request reprint Pharmaceutical care in community pharmacies: practice and research in Canada
    Erika J M Jones
    College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada
    Ann Pharmacother 39:1527-33. 2005
    ....
  76. ncbi request reprint Uptake of new treatment strategies for deep vein thrombosis: an international audit
    Drahomir A Aujesky
    University of Lausanne
    Int J Qual Health Care 16:193-200. 2004
    ....
  77. ncbi request reprint Urban and rural differences in the management of asthma amongst primary care physicians in Alberta
    Elaine Y Lum
    University of British Columbia, Canada
    Can J Clin Pharmacol 14:e275-82. 2007
    ..Inconsistencies in rural and urban health care exist; however, little has been done to evaluate the potential differences in asthma management...
  78. pmc Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies
    J Malcom
    University of Western Ontario, London, Canada
    Can J Cardiol 24:21-40. 2008
    ....
  79. doi request reprint Patient preferences for ongoing warfarin management after receiving care by an anticoagulation management service
    Tammy J Bungard
    Am J Health Syst Pharm 65:1498-500. 2008
  80. ncbi request reprint Cholesterol and osteoporosis in postmenopausal women: a pilot study
    Kannayiram Alagiakrishnan
    J Am Geriatr Soc 51:1510-1. 2003
  81. ncbi request reprint Transition from unfractionated heparin to low molecular weight heparins
    William A Ghali
    Thromb Haemost 88:539-40. 2002